Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure

References

• Eastell R, O’neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT, Cummings SR. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2:16069. doi:10.1038/nrdp.2016.69.
   PubMed Web of Science ®Google Scholar
• Khosla S, Shane E. A crisis in the treatment of osteoporosis. J Bone Miner Res. 2016;31(8):1485–23. doi:10.1002/jbmr.2888.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Gao W, Wang B, Zhao H, Zeng Y, Ji Y, Hao D. Diversity analysis of gut microbiota in osteoporosis and osteopenia patients. Peer J. 2017;5:e3450–e3450. doi:10.7717/peerj.3450.
   PubMed Web of Science ®Google Scholar
• Cheng S, Qi X, Ma M, Zhang L, Cheng B, Liang C, Liu L, Li P, Kafle OP, Wen Y, et al. Assessing the relationship between gut microbiota and bone mineral density. Front Genet. 2020;11(6). doi:10.3389/fgene.2020.00006
   Google Scholar
• Zhou T, Wang M, Ma H, Li X, Heianza Y, Qi L. Dietary fiber, genetic variations of gut microbiota-derived short-chain fatty acids, and bone health in UK Biobank. J Clin Endocrinol Metab. 2021;106(1):201–210. doi:10.1210/clinem/dgaa740.
   PubMed Web of Science ®Google Scholar
• Palacios-González B, Ramírez-Salazar EG, Rivera-Paredez B, Quiterio M, Flores YN, Macias-Kauffer L, Moran-Ramos S, Denova-Gutiérrez E, Ibarra-González I, Vela-Amieva M, et al. A multi-omic analysis for low bone mineral density in postmenopausal women suggests a relationship between diet, metabolites, and microbiota. Microorganisms. 2020;8(11):1630. doi:10.3390/microorganisms8111630.
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–352. doi:10.1038/nri.2016.42.
   PubMed Web of Science ®Google Scholar
• Surana NK, Kasper DL. Deciphering the tête-à-tête between the microbiota and the immune system. J Clin Invest. 2014;124(10):4197–4203. doi:10.1172/jci72332.
   PubMed Web of Science ®Google Scholar
• Tu Y, Yang R, Xu X, Zhou X. The microbiota-gut-bone axis and bone health. J Leukoc Biol. 2021;110(3):525–537. doi:10.1002/jlb.3mr0321-755r.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68(8):1516–1526. doi:10.1136/gutjnl-2019-318427.
   PubMed Web of Science ®Google Scholar
• Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011;141(5):769–776. doi:10.3945/jn.110.135657.
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673–2682. doi:10.1084/jem.20061775.
   PubMed Web of Science ®Google Scholar
• Li JY, Chassaing B, Tyagi AM, Vaccaro C, Luo T, Adams J, Darby TM, Weitzmann MN, Mulle JG, Gewirtz AT, et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest. 2016;126(6):2049–2063. doi:10.1172/jci86062.
   PubMed Web of Science ®Google Scholar
• Shieh A, Epeldegui M, Karlamangla AS, Greendale GA. Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight. 2020;5(2). doi:10.1172/jci.insight.134092.
   PubMed Web of Science ®Google Scholar
• Jia L, Tu Y, Jia X, Du Q, Zheng X, Yuan Q, Zheng L, Zhou X, Xu X. Probiotics ameliorate alveolar bone loss by regulating gut microbiota. Cell Prolif. 2021;54(7):e13075. doi:10.1111/cpr.13075.
   PubMed Web of Science ®Google Scholar
• Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, Parameswaran N, McCabe LR, Probiotic L. Reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol. 2014;229(11):1822–1830. doi:10.1002/jcp.24636.
   PubMed Web of Science ®Google Scholar
• Dar HY, Pal S, Shukla P, Mishra PK, Tomar GB, Chattopadhyay N, Srivastava RK. Bacillus clausii inhibits bone loss by skewing Treg-Th17 cell equilibrium in postmenopausal osteoporotic mice model. Nutrition. 2018;54:118–128. doi:10.1016/j.nut.2018.02.013.
   PubMed Web of Science ®Google Scholar
• Hsu E, Pacifici R. From osteoimmunology to osteomicrobiology: how the microbiota and the immune system regulate bone. Calcif Tissue Int. 2018;102(5):512–521. doi:10.1007/s00223-017-0321-0.
   PubMed Web of Science ®Google Scholar
• Sapra L, Dar HY, Bhardwaj A, Pandey A, Kumari S, Azam Z, Upmanyu V, Anwar A, Shukla P, Mishra PK, et al. Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice. Sci Rep. 2021;11(1):1807. doi:10.1038/s41598-020-80536-2.
   PubMed Web of Science ®Google Scholar
• Xie H, Hua Z, Guo M, Lin S, Zhou Y, Weng Z, Wu L, Chen Z, Xu Z, Li W. Gut microbiota and metabonomics used to explore the mechanism of Qing’e Pills in alleviating osteoporosis. Pharm Biol. 2022;60(1):785–800. doi:10.1080/13880209.2022.2056208.
   PubMed Web of Science ®Google Scholar
• Ardita CS, Mercante JW, Kwon YM, Luo L, Crawford ME, Powell DN, Jones RM, Neish AS. Epithelial adhesion mediated by pilin SpaC is required for Lactobacillus rhamnosus GG-induced cellular responses. Appl Environ Microbiol. 2014;80(16):5068–5077. doi:10.1128/aem.01039-14.
   PubMed Web of Science ®Google Scholar
• Toscano M, De Grandi R, Stronati L, De Vecchi E, Drago L. Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: a preliminary study. World J Gastroenterol. 2017;23(15):2696–2704. doi:10.3748/wjg.v23.i15.2696.
   PubMed Web of Science ®Google Scholar
• Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58(8):1091–1103. doi:10.1136/gut.2008.165886.
   PubMed Web of Science ®Google Scholar
• Schoultz I, Keita ÅV. The intestinal barrier and current techniques for the assessment of gut permeability. Cells. 2020;9(8). doi:10.3390/cells9081909.
   PubMed Web of Science ®Google Scholar
• Dar HY, Shukla P, Mishra PK, Anupam R, Mondal RK, Tomar GB, Sharma V, Srivastava RK. Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance. Bone Rep. 2018;8:46–56. doi:10.1016/j.bonr.2018.02.001.
   PubMedGoogle Scholar
• Tyagi AM, Yu M, Darby TM, Vaccaro C, Li JY, Owens JA, Hsu E, Adams J, Weitzmann MN, Jones RM, et al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B Expression. Immunity. 2018;49(6):1116–1131.e7. doi:10.1016/j.immuni.2018.10.013.
   PubMed Web of Science ®Google Scholar
• Collins FL, Rios-Arce ND, Schepper JD, Parameswaran N, McCabe LR. The potential of probiotics as a therapy for osteoporosis. Microbiol Spectr. 2017;5(4). doi:10.1128/microbiolspec.BAD-0015-2016.
   Web of Science ®Google Scholar
• Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5(11):908–923. doi:10.1016/s2213-8587(17)30184-5.
   PubMed Web of Science ®Google Scholar
• Bhattoa HP, Cavalier E, Eastell R, Heijboer AC, Jørgensen NR, Makris K, Ulmer CZ, Kanis JA, Cooper C, Silverman SL, et al. Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood. Clin Chim Acta. 2021;515:515(16–20. doi:10.1016/j.cca.2020.12.023.
   Web of Science ®Google Scholar
• Wang Z, Chen K, Wu C, Chen J, Pan H, Liu Y, Wu P, Yuan J, Huang F, Lang J, et al. An emerging role of Prevotella histicola on estrogen deficiency-induced bone loss through the gut microbiota-bone axis in postmenopausal women and in ovariectomized mice. Am J Clin Nutr. 2021;114(4):1304–1313. doi:10.1093/ajcn/nqab194.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee J, Li KK, Holland D, Maughan H, Guttman DS, Yusta B, Drucker DJ. Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis. Endocrinology. 2012;153(3):1141–1151. doi:10.1210/en.2011-1954.
   PubMed Web of Science ®Google Scholar
• Drucker DJ, Yusta B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol. 2014;76(1):561–583. doi:10.1146/annurev-physiol-021113-170317.
   PubMedGoogle Scholar
• Li D, Yang Y, Yin X, Liu Y, Xu H, Ni Y, Hang P, Niu S, Zhang H, Ding W, et al. Glucagon-like peptide (GLP) -2 improved colonizing bacteria and reduced severity of ulcerative colitis by enhancing the diversity and abundance of intestinal mucosa. Bioengineered. 2021;12(1):5195–5209. doi:10.1080/21655979.2021.1958600.
   PubMed Web of Science ®Google Scholar
• Yu M, Pal S, Paterson CW, Li JY, Tyagi AM, Adams J, Coopersmith CM, Weitzmann MN, Pacifici R. Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17 cells. J Clin Invest. 2021;131(4). doi:10.1172/jci143137.
   Web of Science ®Google Scholar
• Duncan K, Carey-Ewend K, Vaishnava S. Spatial analysis of gut microbiome reveals a distinct ecological niche associated with the mucus layer. Gut Microbes. 2021;13(1):1874815. doi:10.1080/19490976.2021.1874815.
   PubMed Web of Science ®Google Scholar
• Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN, Shang A, Xu XY, Li HB. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients. 2021;13(9):3211. doi:10.3390/nu13093211.
   PubMed Web of Science ®Google Scholar
• Wu F, Lei H, Chen G, Chen C, Song Y, Cao Z, Zhang C, Zhang C, Zhou J, Lu Y, et al. In Vitro and in vivo studies reveal that hesperetin-7-o-glucoside, a naturally occurring monoglucoside, exhibits strong anti-inflammatory capacity. J Agric Food Chem. 2021;69(43):12753–12762. doi:10.1021/acs.jafc.1c05793.
   PubMed Web of Science ®Google Scholar
• Meng Q, Ma M, Zhang W, Bi Y, Cheng P, Yu X, Fu Y, Chao Y, Ji T, Li J, et al. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites. Gut Microbes. 2021;13(1):1–27. doi:10.1080/19490976.2021.1880220.
   Web of Science ®Google Scholar
• Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022;19(10):625–637. doi:10.1038/s41575-022-00631-9.
   PubMed Web of Science ®Google Scholar
• Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S, et al. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome. 2021;9(1):184. doi:10.1186/s40168-021-01115-9.
   PubMed Web of Science ®Google Scholar
• Qu S, Fan L, Qi Y, Xu C, Hu Y, Chen S, Liu W, Liu W, Si J. Akkermansia muciniphila alleviates Dextran Sulfate Sodium (DSS)-induced acute colitis by NLRP3 activation. Microbiol Spectr. 2021;9(2):e0073021. doi:10.1128/Spectrum.00730-21.
   PubMed Web of Science ®Google Scholar
• Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, Sim D, Jarr K, Spear ET, Singh G, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27(4):659–670.e5. doi:10.1016/j.chom.2020.01.021.
   PubMed Web of Science ®Google Scholar
• Gh VM, van Mierlo G, Jansen P, Vermeulen M, Bleumink-Pluym NMC, Palm NW, Jpm VP, de Zoete MR. Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader. Gut Microbes. 2021;13(1):1966278. doi:10.1080/19490976.2021.1966278.
   PubMed Web of Science ®Google Scholar
• Zheng X, Liu B, Wang N, Yang J, Zhou Q, Sun C, Zhao Y. Low fish meal diet supplemented with probiotics ameliorates intestinal barrier and immunological function of Macrobrachium rosenbergii via the targeted modulation of gut microbes and derived secondary metabolites. Front Immunol. 2022;13:1074399. doi:10.3389/fimmu.2022.1074399.
   PubMed Web of Science ®Google Scholar
• Sun L, Jia H, Li J, Yu M, Yang Y, Tian D, Zhang H, Zou Z. Cecal gut microbiota and metabolites might contribute to the severity of acute myocardial ischemia by impacting the intestinal permeability, oxidative stress, and energy metabolism. Front Microbiol. 2019;10:1745. doi:10.3389/fmicb.2019.01745.
   PubMed Web of Science ®Google Scholar
• Li X, Li R, Ji B, Zhao L, Wang J, Yan T. Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection. J Transl Med. 2022;20(1):614. doi:10.1186/s12967-022-03825-6.
   PubMed Web of Science ®Google Scholar
• Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17(4):223–237. doi:10.1038/s41575-019-0258-z.
   PubMed Web of Science ®Google Scholar